---
title: Teva pharmaceuticals
summary: Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. 
date: 2025-01-01
tags:
  - Teva pharmaceuticals
  - corporations
image:
  caption: 'Image credit: [**Wikipedia**](https://en.wikipedia.org/wiki/Teva_Pharmaceuticals#/media/File:TevaPharm.svg)'
---

Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.

In 2010, Teva acquired the German pharmaceutical company **Ratiopharm**.


## Institutional shareholders and partnerships

```markmap
- institutional 
  shareholders  
  and partnerships
  - Institutional 
    shareholders
    - The Vanguard 
      Group
    - Norges Bank  
      Investment 
      Management
    - KSM Mutual 
      Funds Ltd.
    - Meitav Mutual 
      Funds Ltd.
    - Migdal Mutual 
      Funds Ltd.
    - Harel Mutual 
      Funds Ltd.
    - Charles Schwab 
      Investment 
      Management Inc.
    - Canada Pension Plan 
      Investment Board
    - Vanguard Global 
      Advisers LLC
    - APG Asset 
      Management NV
  - Ratiopharm DE
  - Mepha CH
  - Takeda JP
    - divestment
  - mAbxience 
    partnership
    - Fresenius Kabi
    - Insud Pharma
  - Cephalon
  - Medincell 
    partnership
    - UZEDY® - schizophrenia
    - Perseris®      
  - recently 
    bought 
    shares
    - Migdal Mutual 
      Funds Ltd.
    - Yelin Lapidot 
      Mutual Fund 
      Management Ltd.
    - Phoenix 
      Provident 
      Fund Ltd.
    - KSM Mutual 
      Funds Ltd.
    - State of Wisconsin 
      Investment Board  
```


## Products

```markmap
- Teva Pharmaceuticals 
  Industries products    
  - Duvakitug
    - Ulcerative Colitis
    - Crohn’s Disease
    - inflammatory 
      bowel disease
  - AirDuo® RespiClick®  
  - ProAir® HFA
  - SteadyTeqT
  - UZEDY®
  - AJOVY®
    - migraine    
  - Diclox forte
    - painkiller  
  - SELARSDI™
  - SIMLANDI®
  - Prolia®
  - Copaxone
  - Sandostatin®
    - severe diarrhea 
      for carcinoid 
      syndrome  
  - Ratiopharm
    - Clonidin
      - antihypertensives
    - paracetamol 
      fever syrup     
```




## Scandals

```markmap
- Teva Pharmaceuticals 
  Industries scandals
  - 2019 price fixing USA
    - diabetes
    - cholesterol
    - hypertension
    - cancer
    - epilepsy
  - 2024 patent 
    to exclude 
    firms entry EU
    - multiple sklerose
    - copaxone
    - glatirameracetat
    - 462,6 m 
      Euro fine  
  - 2013 diuretic
    - Furosémide
  - 2014 Mylan SAS
  - 2019 opioide crisis      
```
